speb/financial-data huggingface dataset:
CDR.AX income_statement (annual, 2025-06-30) — Basic Average Shares: 169238994.00
CDR.AX income_statement (annual, 2025-06-30) — Basic EPS: -0.01
CDR.AX income_statement (annual, 2025-06-30) — Diluted Average Shares: 169238994.00
CDR.AX income_statement (annual, 2025-06-30) — Diluted EPS: -0.01
CDR.TO cash_flow (annual, 2021-12-31) — Asset Impairment Charge: 2461000.00
CDR.TO income_statement (annual, 2021-12-31) — Basic Average Shares: 44231402.00
CDR.TO income_statement (annual, 2021-12-31) — Basic EPS: -0.26
CDR.TO income_statement (annual, 2021-12-31) — Diluted Average Shares: 44231402.00
CDR.TO income_statement (annual, 2021-12-31) — Diluted EPS: -0.26
CDR.TO balance_sheet (annual, 2021-12-31) — Foreign Currency Translation Adjustments: -84580000.00
CDR.TO income_statement (annual, 2021-12-31) — Impairment Of Capital Assets: 2461000.00
CDR.TO income_statement (annual, 2021-12-31) — Other Operating Expenses: 2612000.00
CDR.TO cash_flow (annual, 2021-12-31) — Proceeds From Stock Option Exercised: 357000.00
CDR.TO cash_flow (annual, 2021-12-31) — Purchase Of PPE: -89000.00
CDR.TO balance_sheet (annual, 2021-12-31) — Raw Materials: 69000.00
CDR.TO balance_sheet (annual, 2021-12-31) — Restricted Cash: 0.00
CDR.TO income_statement (annual, 2022-12-31) — +Operating Expense: 5475000.00
CDR.TO income_statement (annual, 2022-12-31) — +Total Revenue: 3607000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Accounts Payable: 1626000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Accounts Receivable: 353000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Accumulated Depreciation: -13845000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Additional Paid In Capital: 21686000.00
CDR.TO cash_flow (annual, 2022-12-31) — Asset Impairment Charge: 0.00
CDR.TO balance_sheet (annual, 2022-12-31) — Available For Sale Securities: 417000.00
CDR.TO income_statement (annual, 2022-12-31) — Basic Average Shares: 45739224.00
CDR.TO income_statement (annual, 2022-12-31) — Basic EPS: -0.07
CDR.TO cash_flow (annual, 2022-12-31) — Beginning Cash Position: 4623000.00
CDR.TO cash_flow (annual, 2022-12-31) — Capital Expenditure: -1713000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Capital Lease Obligations: 192000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Capital Stock: 276543000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Cash And Cash Equivalents: 3751000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Cash Cash Equivalents And Short Term Investments: 3751000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Cash Equivalents: 30000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Cash Financial: 3721000.00
CDR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Financing Activities: 3407000.00
CDR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Investing Activities: -1206000.00
CDR.TO cash_flow (annual, 2022-12-31) — Cash Flow From Continuing Operating Activities: -3171000.00
CDR.TO cash_flow (annual, 2022-12-31) — Change In Other Working Capital: -591000.00
CDR.TO cash_flow (annual, 2022-12-31) — Change In Working Capital: -591000.00
CDR.TO cash_flow (annual, 2022-12-31) — Changes In Cash: -970000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Common Stock: 276543000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Common Stock Equity: 6297000.00
CDR.TO cash_flow (annual, 2022-12-31) — Common Stock Issuance: 3728000.00
CDR.TO income_statement (annual, 2022-12-31) — Cost Of Revenue: 2140000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Current Assets: 4404000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Current Capital Lease Obligation: 93000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Current Debt And Capital Lease Obligation: 93000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Current Liabilities: 2014000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Current Provisions: 295000.00
CDR.TO cash_flow (annual, 2022-12-31) — Depreciation Amortization Depletion: 902000.00
CDR.TO income_statement (annual, 2022-12-31) — Diluted Average Shares: 45739224.00
CDR.TO income_statement (annual, 2022-12-31) — Diluted EPS: -0.07
CDR.TO income_statement (annual, 2022-12-31) — Diluted NI Availto Com Stockholders: -3064000.00
CDR.TO income_statement (annual, 2022-12-31) — EBIT: -3060000.00
CDR.TO income_statement (annual, 2022-12-31) — EBITDA: -2158000.00
CDR.TO cash_flow (annual, 2022-12-31) — Effect Of Exchange Rate Changes: 98000.00
CDR.TO cash_flow (annual, 2022-12-31) — End Cash Position: 3751000.00
CDR.TO cash_flow (annual, 2022-12-31) — Financing Cash Flow: 3407000.00
CDR.TO cash_flow (annual, 2022-12-31) — Free Cash Flow: -4884000.00
CDR.TO cash_flow (annual, 2022-12-31) — Gain Loss On Sale Of PPE: -219000.00
CDR.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Ppe: 219000.00
CDR.TO income_statement (annual, 2022-12-31) — Gain On Sale Of Security: 240000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Gains Losses Not Affecting Retained Earnings: -83930000.00
CDR.TO income_statement (annual, 2022-12-31) — General And Administrative Expense: 5523000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Gross PPE: 19086000.00
CDR.TO income_statement (annual, 2022-12-31) — Gross Profit: 1467000.00
CDR.TO income_statement (annual, 2022-12-31) — Impairment Of Capital Assets: 0.00
CDR.TO income_statement (annual, 2022-12-31) — Interest Expense: 4000.00
CDR.TO income_statement (annual, 2022-12-31) — Interest Expense Non Operating: 4000.00
CDR.TO income_statement (annual, 2022-12-31) — Interest Income: 32000.00
CDR.TO income_statement (annual, 2022-12-31) — Interest Income Non Operating: 32000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Inventory: 84000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Invested Capital: 6297000.00
CDR.TO cash_flow (annual, 2022-12-31) — Investing Cash Flow: -1206000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Investmentin Financial Assets: 417000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Investments And Advances: 417000.00
CDR.TO cash_flow (annual, 2022-12-31) — Issuance Of Capital Stock: 3728000.00
CDR.TO cash_flow (annual, 2022-12-31) — Issuance Of Debt: 0.00
CDR.TO balance_sheet (annual, 2022-12-31) — Long Term Capital Lease Obligation: 99000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Long Term Debt And Capital Lease Obligation: 99000.00
CDR.TO cash_flow (annual, 2022-12-31) — Long Term Debt Issuance: 0.00
CDR.TO cash_flow (annual, 2022-12-31) — Long Term Debt Payments: 0.00
CDR.TO balance_sheet (annual, 2022-12-31) — Long Term Provisions: 1652000.00
CDR.TO cash_flow (annual, 2022-12-31) — Net Common Stock Issuance: 3728000.00
CDR.TO cash_flow (annual, 2022-12-31) — Net Foreign Currency Exchange Gain Loss: -552000.00
CDR.TO income_statement (annual, 2022-12-31) — Net Income: -3064000.00
CDR.TO income_statement (annual, 2022-12-31) — Net Income Common Stockholders: -3064000.00
CDR.TO income_statement (annual, 2022-12-31) — Net Income Continuous Operations: -3064000.00
CDR.TO income_statement (annual, 2022-12-31) — Net Income From Continuing And Discontinued Operation: -3064000.00
CDR.TO income_statement (annual, 2022-12-31) — Net Income From Continuing Operation Net Minority Interest: -3064000.00
CDR.TO cash_flow (annual, 2022-12-31) — Net Income From Continuing Operations: -3064000.00
CDR.TO income_statement (annual, 2022-12-31) — Net Income Including Noncontrolling Interests: -3064000.00
CDR.TO income_statement (annual, 2022-12-31) — Net Interest Income: -154000.00
CDR.TO cash_flow (annual, 2022-12-31) — Net Issuance Payments Of Debt: 0.00
CDR.TO cash_flow (annual, 2022-12-31) — Net Long Term Debt Issuance: 0.00
CDR.TO income_statement (annual, 2022-12-31) — Net Non Operating Interest Income Expense: -154000.00
CDR.TO cash_flow (annual, 2022-12-31) — Net Other Financing Charges: -321000.00
CDR.TO cash_flow (annual, 2022-12-31) — Net Other Investing Changes: 285000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Net PPE: 5241000.00
CDR.TO cash_flow (annual, 2022-12-31) — Net PPE Purchase And Sale: -1491000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Net Tangible Assets: 6297000.00
CDR.TO income_statement (annual, 2022-12-31) — Normalized EBITDA: -3204000.00
CDR.TO income_statement (annual, 2022-12-31) — Normalized Income: -4110000.00
CDR.TO cash_flow (annual, 2022-12-31) — Operating Cash Flow: -3171000.00
CDR.TO cash_flow (annual, 2022-12-31) — Operating Gains Losses: -771000.00
CDR.TO income_statement (annual, 2022-12-31) — Operating Income: -4008000.00
CDR.TO income_statement (annual, 2022-12-31) — Operating Revenue: 3607000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Ordinary Shares Number: 56164453.00
CDR.TO balance_sheet (annual, 2022-12-31) — Other Equity Adjustments: -83930000.00
CDR.TO income_statement (annual, 2022-12-31) — Other Gand A: 5242000.00
CDR.TO income_statement (annual, 2022-12-31) — Other Income Expense: 1098000.00
CDR.TO cash_flow (annual, 2022-12-31) — Other Non Cash Items: 72000.00
CDR.TO income_statement (annual, 2022-12-31) — Other Non Operating Income Expenses: 52000.00
CDR.TO income_statement (annual, 2022-12-31) — Other Operating Expenses: -110000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Other Properties: 1800000.00
CDR.TO income_statement (annual, 2022-12-31) — Other Special Charges: -587000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Payables: 1626000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Payables And Accrued Expenses: 1626000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Prepaid Assets: 189000.00
CDR.TO income_statement (annual, 2022-12-31) — Pretax Income: -3064000.00
CDR.TO cash_flow (annual, 2022-12-31) — Proceeds From Stock Option Exercised: 0.00
CDR.TO cash_flow (annual, 2022-12-31) — Purchase Of PPE: -1713000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Raw Materials: 84000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Receivables: 380000.00
CDR.TO income_statement (annual, 2022-12-31) — Reconciled Cost Of Revenue: 2140000.00
CDR.TO income_statement (annual, 2022-12-31) — Reconciled Depreciation: 902000.00
CDR.TO cash_flow (annual, 2022-12-31) — Repayment Of Debt: 0.00
CDR.TO balance_sheet (annual, 2022-12-31) — Retained Earnings: -208002000.00
CDR.TO income_statement (annual, 2022-12-31) — Salaries And Wages: 281000.00
CDR.TO cash_flow (annual, 2022-12-31) — Sale Of PPE: 222000.00
CDR.TO income_statement (annual, 2022-12-31) — Selling And Marketing Expense: 62000.00
CDR.TO income_statement (annual, 2022-12-31) — Selling General And Administration: 5585000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Share Issued: 56164453.00
CDR.TO income_statement (annual, 2022-12-31) — Special Income Charges: 806000.00
CDR.TO cash_flow (annual, 2022-12-31) — Stock Based Compensation: 281000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Stockholders Equity: 6297000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Tangible Book Value: 6297000.00
CDR.TO income_statement (annual, 2022-12-31) — Tax Effect Of Unusual Items: 0.00
CDR.TO income_statement (annual, 2022-12-31) — Tax Rate For Calcs: 0.00
CDR.TO balance_sheet (annual, 2022-12-31) — Taxes Receivable: 27000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Total Assets: 10062000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Total Capitalization: 6297000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Total Debt: 192000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Total Equity Gross Minority Interest: 6297000.00
CDR.TO income_statement (annual, 2022-12-31) — Total Expenses: 7615000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Total Liabilities Net Minority Interest: 3765000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Total Non Current Assets: 5658000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Total Non Current Liabilities Net Minority Interest: 1751000.00
CDR.TO income_statement (annual, 2022-12-31) — Total Other Finance Cost: 182000.00
CDR.TO income_statement (annual, 2022-12-31) — Total Unusual Items: 1046000.00
CDR.TO income_statement (annual, 2022-12-31) — Total Unusual Items Excluding Goodwill: 1046000.00
CDR.TO balance_sheet (annual, 2022-12-31) — Working Capital: 2390000.00
CDR.TO income_statement (annual, 2023-12-31) — +Operating Expense: 5782000.00
CDR.TO income_statement (annual, 2023-12-31) — +Total Revenue: 643000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Accounts Payable: 680000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Accounts Receivable: 21000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Accumulated Depreciation: -14140000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Additional Paid In Capital: 24553000.00
CDR.TO cash_flow (annual, 2023-12-31) — Asset Impairment Charge: 4504000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Available For Sale Securities: 269000.00
CDR.TO income_statement (annual, 2023-12-31) — Basic Average Shares: 56293059.00
CDR.TO income_statement (annual, 2023-12-31) — Basic EPS: -0.20
CDR.TO cash_flow (annual, 2023-12-31) — Beginning Cash Position: 3751000.00
CDR.TO cash_flow (annual, 2023-12-31) — Capital Expenditure: -215000.00
CDR.TO cash_flow (annual, 2023-12-31) — Capital Expenditure Reported: -215000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Capital Lease Obligations: 130000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Capital Stock: 276722000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Cash And Cash Equivalents: 5043000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Cash Cash Equivalents And Short Term Investments: 5043000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Cash Equivalents: 30000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Cash Financial: 5013000.00
CDR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Financing Activities: 7716000.00
CDR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Investing Activities: -1080000.00
CDR.TO cash_flow (annual, 2023-12-31) — Cash Flow From Continuing Operating Activities: -5353000.00
CDR.TO cash_flow (annual, 2023-12-31) — Change In Other Current Liabilities: 0.00
CDR.TO cash_flow (annual, 2023-12-31) — Change In Other Working Capital: -137000.00
CDR.TO cash_flow (annual, 2023-12-31) — Change In Working Capital: -137000.00
CDR.TO cash_flow (annual, 2023-12-31) — Changes In Cash: 1283000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Common Stock: 276722000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Common Stock Equity: -2533000.00
CDR.TO cash_flow (annual, 2023-12-31) — Common Stock Issuance: 124000.00
CDR.TO income_statement (annual, 2023-12-31) — Cost Of Revenue: 2481000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Current Assets: 5579000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Current Capital Lease Obligation: 42000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Current Debt And Capital Lease Obligation: 649000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Current Liabilities: 1964000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Current Provisions: 635000.00
CDR.TO cash_flow (annual, 2023-12-31) — Deferred Income Tax: 0.00
CDR.TO cash_flow (annual, 2023-12-31) — Deferred Tax: 0.00
CDR.TO cash_flow (annual, 2023-12-31) — Depreciation Amortization Depletion: 1569000.00
CDR.TO income_statement (annual, 2023-12-31) — Diluted Average Shares: 56293059.00
CDR.TO income_statement (annual, 2023-12-31) — Diluted EPS: -0.20
CDR.TO income_statement (annual, 2023-12-31) — Diluted NI Availto Com Stockholders: -11392000.00
CDR.TO income_statement (annual, 2023-12-31) — EBIT: -10684000.00
CDR.TO income_statement (annual, 2023-12-31) — EBITDA: -9115000.00
CDR.TO cash_flow (annual, 2023-12-31) — Effect Of Exchange Rate Changes: 9000.00
CDR.TO cash_flow (annual, 2023-12-31) — End Cash Position: 5043000.00
CDR.TO cash_flow (annual, 2023-12-31) — Financing Cash Flow: 7716000.00
CDR.TO cash_flow (annual, 2023-12-31) — Free Cash Flow: -5568000.00
CDR.TO cash_flow (annual, 2023-12-31) — Gain Loss On Sale Of PPE: -199000.00
CDR.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Ppe: 199000.00
CDR.TO income_statement (annual, 2023-12-31) — Gain On Sale Of Security: 151000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Gains Losses Not Affecting Retained Earnings: -84414000.00
CDR.TO income_statement (annual, 2023-12-31) — General And Administrative Expense: 5763000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Gross PPE: 15061000.00
CDR.TO income_statement (annual, 2023-12-31) — Gross Profit: -1838000.00
CDR.TO income_statement (annual, 2023-12-31) — Impairment Of Capital Assets: 4504000.00
CDR.TO income_statement (annual, 2023-12-31) — Interest Expense: 708000.00
CDR.TO income_statement (annual, 2023-12-31) — Interest Expense Non Operating: 708000.00
CDR.TO income_statement (annual, 2023-12-31) — Interest Income: 188000.00
CDR.TO income_statement (annual, 2023-12-31) — Interest Income Non Operating: 188000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Inventory: 59000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Invested Capital: 2883000.00
CDR.TO cash_flow (annual, 2023-12-31) — Investing Cash Flow: -1080000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Investmentin Financial Assets: 269000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Investments And Advances: 269000.00
CDR.TO cash_flow (annual, 2023-12-31) — Issuance Of Capital Stock: 124000.00
CDR.TO cash_flow (annual, 2023-12-31) — Issuance Of Debt: 7779000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Long Term Capital Lease Obligation: 88000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Long Term Debt: 5416000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Long Term Debt And Capital Lease Obligation: 5504000.00
CDR.TO cash_flow (annual, 2023-12-31) — Long Term Debt Issuance: 7779000.00
CDR.TO cash_flow (annual, 2023-12-31) — Long Term Debt Payments: -105000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Long Term Provisions: 1834000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Minority Interest: 0.00
CDR.TO income_statement (annual, 2023-12-31) — Minority Interests: 0.00
CDR.TO cash_flow (annual, 2023-12-31) — Net Common Stock Issuance: 124000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Net Debt: 373000.00
CDR.TO cash_flow (annual, 2023-12-31) — Net Foreign Currency Exchange Gain Loss: -974000.00
CDR.TO income_statement (annual, 2023-12-31) — Net Income: -11392000.00
CDR.TO income_statement (annual, 2023-12-31) — Net Income Common Stockholders: -11392000.00
CDR.TO income_statement (annual, 2023-12-31) — Net Income Continuous Operations: -11392000.00
CDR.TO income_statement (annual, 2023-12-31) — Net Income From Continuing And Discontinued Operation: -11392000.00
CDR.TO income_statement (annual, 2023-12-31) — Net Income From Continuing Operation Net Minority Interest: -11392000.00
CDR.TO cash_flow (annual, 2023-12-31) — Net Income From Continuing Operations: -11392000.00
CDR.TO income_statement (annual, 2023-12-31) — Net Income Including Noncontrolling Interests: -11392000.00
CDR.TO income_statement (annual, 2023-12-31) — Net Interest Income: -569000.00
CDR.TO cash_flow (annual, 2023-12-31) — Net Issuance Payments Of Debt: 7674000.00
CDR.TO cash_flow (annual, 2023-12-31) — Net Long Term Debt Issuance: 7674000.00
CDR.TO income_statement (annual, 2023-12-31) — Net Non Operating Interest Income Expense: -569000.00
CDR.TO cash_flow (annual, 2023-12-31) — Net Other Financing Charges: -82000.00
CDR.TO cash_flow (annual, 2023-12-31) — Net Other Investing Changes: -1096000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Net PPE: 921000.00
CDR.TO cash_flow (annual, 2023-12-31) — Net PPE Purchase And Sale: 231000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Net Tangible Assets: -2533000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Assets: 0.00
CDR.TO balance_sheet (annual, 2023-12-31) — Non Current Deferred Taxes Assets: 0.00
CDR.TO income_statement (annual, 2023-12-31) — Normalized EBITDA: -5963000.00
CDR.TO income_statement (annual, 2023-12-31) — Normalized Income: -8240000.00
CDR.TO cash_flow (annual, 2023-12-31) — Operating Cash Flow: -5353000.00
CDR.TO cash_flow (annual, 2023-12-31) — Operating Gains Losses: -1173000.00
CDR.TO income_statement (annual, 2023-12-31) — Operating Income: -7620000.00
CDR.TO income_statement (annual, 2023-12-31) — Operating Revenue: 643000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Ordinary Shares Number: 56490433.00
CDR.TO balance_sheet (annual, 2023-12-31) — Other Equity Adjustments: -84414000.00
CDR.TO income_statement (annual, 2023-12-31) — Other Gand A: 5031000.00
CDR.TO income_statement (annual, 2023-12-31) — Other Income Expense: -3203000.00
CDR.TO cash_flow (annual, 2023-12-31) — Other Non Cash Items: 544000.00
CDR.TO income_statement (annual, 2023-12-31) — Other Non Operating Income Expenses: -51000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Other Properties: 1652000.00
CDR.TO income_statement (annual, 2023-12-31) — Other Special Charges: -1002000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Payables: 680000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Payables And Accrued Expenses: 680000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Prepaid Assets: 387000.00
CDR.TO income_statement (annual, 2023-12-31) — Pretax Income: -11392000.00
CDR.TO cash_flow (annual, 2023-12-31) — Purchase Of PPE: -215000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Receivables: 90000.00
CDR.TO income_statement (annual, 2023-12-31) — Reconciled Cost Of Revenue: 2481000.00
CDR.TO income_statement (annual, 2023-12-31) — Reconciled Depreciation: 1569000.00
CDR.TO cash_flow (annual, 2023-12-31) — Repayment Of Debt: -105000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Retained Earnings: -219394000.00
CDR.TO income_statement (annual, 2023-12-31) — Salaries And Wages: 732000.00
CDR.TO cash_flow (annual, 2023-12-31) — Sale Of PPE: 231000.00
CDR.TO income_statement (annual, 2023-12-31) — Selling And Marketing Expense: 19000.00
CDR.TO income_statement (annual, 2023-12-31) — Selling General And Administration: 5782000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Share Issued: 56490433.00
CDR.TO income_statement (annual, 2023-12-31) — Special Income Charges: -3303000.00
CDR.TO cash_flow (annual, 2023-12-31) — Stock Based Compensation: 732000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Stockholders Equity: -2533000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Tangible Book Value: -2533000.00
CDR.TO income_statement (annual, 2023-12-31) — Tax Effect Of Unusual Items: 0.00
CDR.TO income_statement (annual, 2023-12-31) — Tax Provision: 0.00
CDR.TO income_statement (annual, 2023-12-31) — Tax Rate For Calcs: 0.00
CDR.TO balance_sheet (annual, 2023-12-31) — Taxes Receivable: 69000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Total Assets: 6769000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Total Capitalization: 2883000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Total Debt: 6153000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Total Equity Gross Minority Interest: -2533000.00
CDR.TO income_statement (annual, 2023-12-31) — Total Expenses: 8263000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Total Liabilities Net Minority Interest: 9302000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Total Non Current Assets: 1190000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Total Non Current Liabilities Net Minority Interest: 7338000.00
CDR.TO income_statement (annual, 2023-12-31) — Total Other Finance Cost: 49000.00
CDR.TO income_statement (annual, 2023-12-31) — Total Unusual Items: -3152000.00
CDR.TO income_statement (annual, 2023-12-31) — Total Unusual Items Excluding Goodwill: -3152000.00
CDR.TO balance_sheet (annual, 2023-12-31) — Working Capital: 3615000.00
CDR.TO balance_sheet (quarterly, 2024-09-30) — Available For Sale Securities: 268000.00
CDR.TO income_statement (quarterly, 2024-09-30) — Basic Average Shares: 57139328.00
CDR.TO income_statement (quarterly, 2024-09-30) — Basic EPS: 0.01
CDR.TO cash_flow (quarterly, 2024-09-30) — Capital Expenditure Reported: -2782000.00
CDR.TO income_statement (quarterly, 2024-09-30) — Diluted Average Shares: 57139328.00
CDR.TO income_statement (quarterly, 2024-09-30) — Diluted EPS: 0.01
CDR.TO cash_flow (quarterly, 2024-09-30) — Gain Loss On Sale Of PPE: 0.00
CDR.TO income_statement (quarterly, 2024-09-30) — Gain On Sale Of Ppe: 0.00
CDR.TO balance_sheet (quarterly, 2024-09-30) — Income Tax Payable: 873000.00
CDR.TO balance_sheet (quarterly, 2024-09-30) — Investmentin Financial Assets: 268000.00
CDR.TO balance_sheet (quarterly, 2024-09-30) — Investments And Advances: 268000.00
CDR.TO income_statement (quarterly, 2024-09-30) — Other Non Operating Income Expenses: -47000.00
CDR.TO income_statement (quarterly, 2024-09-30) — Other Special Charges: -9000.00
CDR.TO cash_flow (quarterly, 2024-09-30) — Sale Of PPE: 0.00
CDR.TO cash_flow (quarterly, 2024-09-30) — Short Term Debt Issuance: 0.00
CDR.TO income_statement (quarterly, 2024-09-30) — Special Income Charges: 9000.00
CDR.TO balance_sheet (quarterly, 2024-09-30) — Total Tax Payable: 873000.00
CDR.TO income_statement (annual, 2024-12-31) — +Operating Expense: 12391000.00
CDR.TO income_statement (annual, 2024-12-31) — +Total Revenue: 66626000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Accounts Payable: 9844000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Accounts Receivable: 17617000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Accumulated Depreciation: -17553000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Additional Paid In Capital: 25297000.00
CDR.TO cash_flow (annual, 2024-12-31) — Asset Impairment Charge: 0.00
CDR.TO balance_sheet (annual, 2024-12-31) — Available For Sale Securities: 279000.00
CDR.TO balance_sheet (quarterly, 2024-12-31) — Available For Sale Securities: 279000.00
CDR.TO income_statement (annual, 2024-12-31) — Basic Average Shares: 57547800.00
CDR.TO income_statement (annual, 2024-12-31) — Basic EPS: -0.07
CDR.TO cash_flow (annual, 2024-12-31) — Beginning Cash Position: 5043000.00
CDR.TO cash_flow (annual, 2024-12-31) — Capital Expenditure: -8278000.00
CDR.TO cash_flow (annual, 2024-12-31) — Capital Expenditure Reported: -8278000.00
CDR.TO cash_flow (quarterly, 2024-12-31) — Capital Expenditure Reported: -3764000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Capital Lease Obligations: 627000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Capital Stock: 75649000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Cash And Cash Equivalents: 27841000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Cash Cash Equivalents And Short Term Investments: 27841000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Cash Equivalents: 30000.00
CDR.TO balance_sheet (quarterly, 2024-12-31) — Cash Equivalents: 30000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Cash Financial: 27811000.00
CDR.TO balance_sheet (quarterly, 2024-12-31) — Cash Financial: 27811000.00
CDR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Financing Activities: 24114000.00
CDR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Investing Activities: -7353000.00
CDR.TO cash_flow (annual, 2024-12-31) — Cash Flow From Continuing Operating Activities: 5357000.00
CDR.TO cash_flow (annual, 2024-12-31) — Change In Other Current Liabilities: 4455000.00
CDR.TO cash_flow (annual, 2024-12-31) — Change In Other Working Capital: -11047000.00
CDR.TO cash_flow (annual, 2024-12-31) — Change In Working Capital: -6592000.00
CDR.TO cash_flow (annual, 2024-12-31) — Changes In Cash: 22118000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Common Stock: 75649000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Common Stock Equity: 13333000.00
CDR.TO cash_flow (annual, 2024-12-31) — Common Stock Issuance: 19623000.00
CDR.TO income_statement (annual, 2024-12-31) — Cost Of Revenue: 41285000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Current Assets: 47703000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Current Capital Lease Obligation: 205000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Current Debt: 7781000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Current Debt And Capital Lease Obligation: 10168000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Current Liabilities: 21726000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Current Provisions: 1242000.00
CDR.TO cash_flow (annual, 2024-12-31) — Deferred Income Tax: -229000.00
CDR.TO cash_flow (annual, 2024-12-31) — Deferred Tax: -229000.00
CDR.TO cash_flow (annual, 2024-12-31) — Depreciation Amortization Depletion: 5773000.00
CDR.TO income_statement (annual, 2024-12-31) — Diluted Average Shares: 57547800.00
CDR.TO income_statement (annual, 2024-12-31) — Diluted EPS: -0.07
CDR.TO income_statement (annual, 2024-12-31) — Diluted NI Availto Com Stockholders: -4072000.00
CDR.TO income_statement (annual, 2024-12-31) — EBIT: 8711000.00
CDR.TO income_statement (annual, 2024-12-31) — EBITDA: 14484000.00
CDR.TO cash_flow (annual, 2024-12-31) — Effect Of Exchange Rate Changes: 680000.00
CDR.TO cash_flow (annual, 2024-12-31) — End Cash Position: 27841000.00
CDR.TO cash_flow (annual, 2024-12-31) — Financing Cash Flow: 24114000.00
CDR.TO cash_flow (annual, 2024-12-31) — Free Cash Flow: -2921000.00
CDR.TO cash_flow (annual, 2024-12-31) — Gain Loss On Investment Securities: 687000.00
CDR.TO cash_flow (annual, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
CDR.TO cash_flow (quarterly, 2024-12-31) — Gain Loss On Sale Of PPE: 0.00
CDR.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Ppe: 0.00
CDR.TO income_statement (quarterly, 2024-12-31) — Gain On Sale Of Ppe: 0.00
CDR.TO income_statement (annual, 2024-12-31) — Gain On Sale Of Security: -1895000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Gains Losses Not Affecting Retained Earnings: -83724000.00
CDR.TO income_statement (annual, 2024-12-31) — General And Administrative Expense: 10020000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Gross PPE: 35949000.00
CDR.TO income_statement (annual, 2024-12-31) — Gross Profit: 25341000.00
CDR.TO income_statement (annual, 2024-12-31) — Impairment Of Capital Assets: 0.00
CDR.TO income_statement (annual, 2024-12-31) — Interest Expense: 2220000.00
CDR.TO income_statement (annual, 2024-12-31) — Interest Expense Non Operating: 2220000.00
CDR.TO income_statement (annual, 2024-12-31) — Interest Income: 180000.00
CDR.TO income_statement (annual, 2024-12-31) — Interest Income Non Operating: 180000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Inventory: 624000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Invested Capital: 25891000.00
CDR.TO cash_flow (annual, 2024-12-31) — Investing Cash Flow: -7353000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Investmentin Financial Assets: 279000.00
CDR.TO balance_sheet (quarterly, 2024-12-31) — Investmentin Financial Assets: 279000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Investments And Advances: 279000.00
CDR.TO balance_sheet (quarterly, 2024-12-31) — Investments And Advances: 279000.00
CDR.TO cash_flow (annual, 2024-12-31) — Issuance Of Capital Stock: 19623000.00
CDR.TO cash_flow (annual, 2024-12-31) — Issuance Of Debt: 6463000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Long Term Capital Lease Obligation: 422000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Long Term Debt: 4777000.00
CDR.TO balance_sheet (quarterly, 2024-12-31) — Long Term Debt: 4777000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Long Term Debt And Capital Lease Obligation: 5199000.00
CDR.TO cash_flow (annual, 2024-12-31) — Long Term Debt Issuance: 6463000.00
CDR.TO cash_flow (quarterly, 2024-12-31) — Long Term Debt Issuance: 0.00
CDR.TO cash_flow (annual, 2024-12-31) — Long Term Debt Payments: -575000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Long Term Provisions: 14457000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Machinery Furniture Equipment: 0.00
CDR.TO balance_sheet (quarterly, 2024-12-31) — Machinery Furniture Equipment: 0.00
CDR.TO balance_sheet (annual, 2024-12-31) — Minority Interest: 7727000.00
CDR.TO income_statement (annual, 2024-12-31) — Minority Interests: -7565000.00
CDR.TO cash_flow (annual, 2024-12-31) — Net Common Stock Issuance: 19623000.00
CDR.TO cash_flow (annual, 2024-12-31) — Net Foreign Currency Exchange Gain Loss: 1223000.00
CDR.TO income_statement (annual, 2024-12-31) — Net Income: -4072000.00
CDR.TO income_statement (annual, 2024-12-31) — Net Income Common Stockholders: -4072000.00
CDR.TO income_statement (annual, 2024-12-31) — Net Income Continuous Operations: 3493000.00
CDR.TO income_statement (annual, 2024-12-31) — Net Income From Continuing And Discontinued Operation: -4072000.00
CDR.TO income_statement (annual, 2024-12-31) — Net Income From Continuing Operation Net Minority Interest: -4072000.00
CDR.TO cash_flow (annual, 2024-12-31) — Net Income From Continuing Operations: 3493000.00
CDR.TO income_statement (annual, 2024-12-31) — Net Income Including Noncontrolling Interests: 3493000.00
CDR.TO income_statement (annual, 2024-12-31) — Net Interest Income: -2732000.00
CDR.TO cash_flow (annual, 2024-12-31) — Net Issuance Payments Of Debt: 5888000.00
CDR.TO cash_flow (annual, 2024-12-31) — Net Long Term Debt Issuance: 5888000.00
CDR.TO income_statement (annual, 2024-12-31) — Net Non Operating Interest Income Expense: -2732000.00
CDR.TO cash_flow (annual, 2024-12-31) — Net Other Financing Charges: -1397000.00
CDR.TO cash_flow (quarterly, 2024-12-31) — Net Other Financing Charges: -1253000.00
CDR.TO cash_flow (annual, 2024-12-31) — Net Other Investing Changes: 925000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Net PPE: 18396000.00
CDR.TO cash_flow (annual, 2024-12-31) — Net PPE Purchase And Sale: 0.00
CDR.TO cash_flow (annual, 2024-12-31) — Net Short Term Debt Issuance: 0.00
CDR.TO balance_sheet (annual, 2024-12-31) — Net Tangible Assets: 13333000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Assets: 229000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Non Current Deferred Taxes Assets: 229000.00
CDR.TO income_statement (annual, 2024-12-31) — Normalized EBITDA: 16294000.00
CDR.TO income_statement (annual, 2024-12-31) — Normalized Income: -2533500.00
CDR.TO cash_flow (annual, 2024-12-31) — Operating Cash Flow: 5357000.00
CDR.TO cash_flow (annual, 2024-12-31) — Operating Gains Losses: 1910000.00
CDR.TO income_statement (annual, 2024-12-31) — Operating Income: 12950000.00
CDR.TO income_statement (annual, 2024-12-31) — Operating Revenue: 66626000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Ordinary Shares Number: 67457117.00
CDR.TO balance_sheet (annual, 2024-12-31) — Other Current Borrowings: 7781000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Other Current Liabilities: 472000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Other Equity Adjustments: -83724000.00
CDR.TO income_statement (annual, 2024-12-31) — Other Gand A: 9325000.00
CDR.TO income_statement (annual, 2024-12-31) — Other Income Expense: -3727000.00
CDR.TO cash_flow (annual, 2024-12-31) — Other Non Cash Items: 307000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Other Non Current Liabilities: 4165000.00
CDR.TO income_statement (annual, 2024-12-31) — Other Non Operating Income Expenses: -1917000.00
CDR.TO income_statement (quarterly, 2024-12-31) — Other Non Operating Income Expenses: 0.00
CDR.TO balance_sheet (annual, 2024-12-31) — Other Properties: 2397000.00
CDR.TO income_statement (annual, 2024-12-31) — Other Special Charges: -85000.00
CDR.TO income_statement (quarterly, 2024-12-31) — Other Special Charges: -72000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Payables: 9844000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Payables And Accrued Expenses: 9844000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Prepaid Assets: 1209000.00
CDR.TO income_statement (annual, 2024-12-31) — Pretax Income: 6491000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Receivables: 18029000.00
CDR.TO income_statement (annual, 2024-12-31) — Reconciled Cost Of Revenue: 41285000.00
CDR.TO income_statement (annual, 2024-12-31) — Reconciled Depreciation: 5773000.00
CDR.TO cash_flow (annual, 2024-12-31) — Repayment Of Debt: -575000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Retained Earnings: -3889000.00
CDR.TO income_statement (annual, 2024-12-31) — Salaries And Wages: 695000.00
CDR.TO cash_flow (annual, 2024-12-31) — Sale Of PPE: 0.00
CDR.TO cash_flow (quarterly, 2024-12-31) — Sale Of PPE: 0.00
CDR.TO income_statement (annual, 2024-12-31) — Selling And Marketing Expense: 2371000.00
CDR.TO income_statement (annual, 2024-12-31) — Selling General And Administration: 12391000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Share Issued: 67457117.00
CDR.TO cash_flow (annual, 2024-12-31) — Short Term Debt Issuance: 0.00
CDR.TO income_statement (annual, 2024-12-31) — Special Income Charges: 85000.00
CDR.TO income_statement (quarterly, 2024-12-31) — Special Income Charges: 72000.00
CDR.TO cash_flow (annual, 2024-12-31) — Stock Based Compensation: 695000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Stockholders Equity: 13333000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Tangible Book Value: 13333000.00
CDR.TO income_statement (annual, 2024-12-31) — Tax Effect Of Unusual Items: -271500.00
CDR.TO income_statement (annual, 2024-12-31) — Tax Provision: 2998000.00
CDR.TO income_statement (annual, 2024-12-31) — Tax Rate For Calcs: 0.15
CDR.TO balance_sheet (annual, 2024-12-31) — Taxes Receivable: 412000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Total Assets: 66607000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Total Capitalization: 18110000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Total Debt: 15367000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Total Equity Gross Minority Interest: 21060000.00
CDR.TO income_statement (annual, 2024-12-31) — Total Expenses: 53676000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Total Liabilities Net Minority Interest: 45547000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Total Non Current Assets: 18904000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Total Non Current Liabilities Net Minority Interest: 23821000.00
CDR.TO income_statement (annual, 2024-12-31) — Total Other Finance Cost: 692000.00
CDR.TO income_statement (annual, 2024-12-31) — Total Unusual Items: -1810000.00
CDR.TO income_statement (annual, 2024-12-31) — Total Unusual Items Excluding Goodwill: -1810000.00
CDR.TO balance_sheet (annual, 2024-12-31) — Working Capital: 25977000.00
CDR.TO income_statement (quarterly, 2025-03-31) — +Operating Expense: 3888000.00
CDR.TO income_statement (quarterly, 2025-03-31) — +Total Revenue: 22270000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Accounts Payable: 8962000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Accounts Receivable: 8223000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Accumulated Depreciation: -20517000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Additional Paid In Capital: 25987000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Basic Average Shares: 67462561.00
CDR.TO income_statement (quarterly, 2025-03-31) — Basic EPS: 0.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Beginning Cash Position: 27841000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Capital Expenditure: -9059000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Capital Lease Obligations: 721000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Capital Stock: 75657000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Cash And Cash Equivalents: 33118000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Cash Cash Equivalents And Short Term Investments: 33118000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Financing Activities: -580000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Investing Activities: -9049000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Cash Flow From Continuing Operating Activities: 14859000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Change In Other Current Liabilities: 852000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Change In Other Working Capital: 9048000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Change In Working Capital: 9900000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Changes In Cash: 5230000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Common Stock: 75657000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Common Stock Equity: 13980000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Common Stock Issuance: 5000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Cost Of Revenue: 15406000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Current Assets: 43497000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Current Capital Lease Obligation: 239000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Current Debt: 7442000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Current Debt And Capital Lease Obligation: 9848000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Current Liabilities: 21256000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Current Provisions: 1277000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Deferred Income Tax: -611000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Deferred Tax: -611000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Depreciation Amortization Depletion: 3276000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Diluted Average Shares: 67462561.00
CDR.TO income_statement (quarterly, 2025-03-31) — Diluted EPS: 0.00
CDR.TO income_statement (quarterly, 2025-03-31) — Diluted NI Availto Com Stockholders: -85000.00
CDR.TO income_statement (quarterly, 2025-03-31) — EBIT: 3186000.00
CDR.TO income_statement (quarterly, 2025-03-31) — EBITDA: 6462000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Effect Of Exchange Rate Changes: 47000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — End Cash Position: 33118000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Financing Cash Flow: -580000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Free Cash Flow: 5800000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Gain Loss On Investment Securities: -265000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Gain On Sale Of Security: 288000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Gains Losses Not Affecting Retained Earnings: -83690000.00
CDR.TO income_statement (quarterly, 2025-03-31) — General And Administrative Expense: 3185000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Gross PPE: 44325000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Gross Profit: 6864000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Income Tax Payable: 678000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Interest Expense: 809000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Interest Expense Non Operating: 809000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Interest Income: 99000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Interest Income Non Operating: 99000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Inventory: 776000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Invested Capital: 25870000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Investing Cash Flow: -9049000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Capital Stock: 5000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Issuance Of Debt: 0.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Long Term Capital Lease Obligation: 482000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt: 4448000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Long Term Debt And Capital Lease Obligation: 4930000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Issuance: 0.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Long Term Debt Payments: -585000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Long Term Provisions: 13868000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Minority Interest: 9434000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Minority Interests: -1709000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Net Common Stock Issuance: 5000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Net Foreign Currency Exchange Gain Loss: -231000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Net Income: -85000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Net Income Common Stockholders: -85000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Net Income Continuous Operations: 1624000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing And Discontinued Operation: -85000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Net Income From Continuing Operation Net Minority Interest: -85000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Net Income From Continuing Operations: 1624000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Net Income Including Noncontrolling Interests: 1624000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Net Interest Income: -874000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Net Issuance Payments Of Debt: -585000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Net Long Term Debt Issuance: -585000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Net Non Operating Interest Income Expense: -874000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Net Other Investing Changes: 10000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Net PPE: 23808000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Net PPE Purchase And Sale: -9059000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Net Short Term Debt Issuance: 0.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Net Tangible Assets: 13980000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Assets: 847000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Non Current Deferred Taxes Assets: 847000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Normalized EBITDA: 6174000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Normalized Income: -281765.67
CDR.TO cash_flow (quarterly, 2025-03-31) — Operating Cash Flow: 14859000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Operating Gains Losses: -496000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Operating Income: 2976000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Operating Revenue: 22270000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Ordinary Shares Number: 67467117.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Other Current Borrowings: 7442000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Other Current Liabilities: 491000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Other Equity Adjustments: -83690000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Other Gand A: 2492000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Other Income Expense: 275000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Other Non Cash Items: 473000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Assets: 275000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Other Non Current Liabilities: 4959000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Other Non Operating Income Expenses: -13000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Other Properties: 2646000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Payables: 9640000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Payables And Accrued Expenses: 9640000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Prepaid Assets: 1193000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Pretax Income: 2377000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Purchase Of PPE: -9059000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Receivables: 8410000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Reconciled Cost Of Revenue: 15406000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Reconciled Depreciation: 3276000.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Repayment Of Debt: -585000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Retained Earnings: -3974000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Salaries And Wages: 693000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Selling And Marketing Expense: 703000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Selling General And Administration: 3888000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Share Issued: 67467117.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Short Term Debt Issuance: 0.00
CDR.TO cash_flow (quarterly, 2025-03-31) — Stock Based Compensation: 693000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Stockholders Equity: 13980000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Tangible Book Value: 13980000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Tax Effect Of Unusual Items: 91234.33
CDR.TO income_statement (quarterly, 2025-03-31) — Tax Provision: 753000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Tax Rate For Calcs: 0.32
CDR.TO balance_sheet (quarterly, 2025-03-31) — Taxes Receivable: 187000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Total Assets: 68427000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Total Capitalization: 18428000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Total Debt: 14778000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Total Equity Gross Minority Interest: 23414000.00
CDR.TO income_statement (quarterly, 2025-03-31) — Total Expenses: 19294000.00
CDR.TO balance_sheet (quarterly, 2025-03-31) — Total Liabilities Net Minority Interest: 45013000.00